Noticias y Eventos
Digital healthcare puts patients in control of their health
Development of digital technology is helping to deliver personalised treatments which involve patients in their healthcare
EP Europace Advance Articles
Click read more to read these advance articles today.
Atrial fibrillation ablation alone or atrial fibrillation ablation plus an antiarrhythmic drug?
The majority of triggers for AF originate in the pulmonary veins,2 which is why electrical isolation of the pulmonary veins is the recommended (class IA) and most common ablation strategy for AF.3 There is evidence that AF ablation improves quality of life and may improve ejection fraction in patients with ...
New Syncope Guidelines Take Aim at ED Bottleneck
BARCELONA, Spain — About half of all people will have an episode of syncope in their lifetime, and up until now, an equal number in any part of the world will have been admitted to the hospital, even if risk for recurrence is low.
Smartwatch May Be Able to Passively Detect Atrial Fibrillation
HealthDay News — A smartwatch coupled with a machine learning algorithm is able to accurately detect atrial fibrillation (AF), with some loss of specificity and sensitivity compared to criterion-standard electrocardiography (ECG), according to a study published online March 21 in JAMA Cardiology.
European Journal of Arrhythmia & Electrophysiology - Volume 4 Issue 1
Get all the feature articles with on click.
Continuous Apixaban Safe During AF Ablation in At-Risk Patients
BARCELONA, Spain — Uninterrupted apixaban appears to be as safe as warfarin and other vitamin K antagonists (VKAs) in patients at risk for stroke undergoing atrial fibrillation (AF) ablation, results of the AXAFA-AFNET 5 trial suggest. The primary composite endpoint of all-cause death, stroke, ...
Bradyarrhythmias and pacemakers
Bradyarrhythmias are heart rhythms with a rate of <60 beats/min, commonly due to conduction abnormalities in the heart such as sinus node disease or atrioventricular block.1 There is increased risk of sudden cardiac death due to slowing or stopping of the heart, and of falls, especially in older people, due to fainting.
Two trials find Medtronic’s algorithm reduces atrial fibrillation
Medtronic has reported successful findings from two real-world analyses conducted to assess its AdaptivCRT algorithm in a total of 408 patients suffering from heart failure.
A huge thank you to Francis White
Thank you to Francis White, Arrhythmia Alliance Executive Committee Member for representing Arrhythmia Alliance.